These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17616435)

  • 1. Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy?
    Padayachee L
    Heart Lung Circ; 2007; 16 Suppl 3():S65-70. PubMed ID: 17616435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of levosimendan in Takotsubo-related cardiogenic shock.
    Antonini M; Stazi GV; Cirasa MT; Garotto G; Frustaci A
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):119-20. PubMed ID: 19961441
    [No Abstract]   [Full Text] [Related]  

  • 3. [Levosimendan for septic shock with takotsubo cardiomyopathy].
    Schlürmann CN; Reinöhl J; Kalbhenn J
    Anaesthesist; 2016 Jan; 65(1):46-49. PubMed ID: 26620046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome.
    De Santis V; Vitale D; Tritapepe L; Greco C; Pietropaoli P
    Ann Intern Med; 2008 Sep; 149(5):365-7. PubMed ID: 18765717
    [No Abstract]   [Full Text] [Related]  

  • 5. Sepsis-associated takotsubo cardiomyopathy can be reversed with levosimendan.
    Karvouniaris M; Papanikolaou J; Makris D; Zakynthinos E
    Am J Emerg Med; 2012 Jun; 30(5):832.e5-7. PubMed ID: 21530136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
    Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
    J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
    [No Abstract]   [Full Text] [Related]  

  • 8. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F; Franco F; Cardoso JS
    Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan reversing low output syndrome after heart transplantation.
    Petäjä LM; Sipponen JT; Hämmäinen PJ; Eriksson HI; Salmenperä MT; Suojaranta-Ylinen RT
    Ann Thorac Surg; 2006 Oct; 82(4):1529-31. PubMed ID: 16996977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 11. Levosimendan: a promising treatment for myocardial stunning?
    Ellger BM; Zahn PK; Van Aken HK; Schmidt C; Brussel T
    Anaesthesia; 2006 Jan; 61(1):61-3. PubMed ID: 16409345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.
    Samimi-Fard S; García-González MJ; Domínguez-Rodríguez A; Abreu-González P
    Int J Cardiol; 2008 Jul; 127(2):284-7. PubMed ID: 17643519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer.
    Varpula T; Rapola J; Sallisalmi M; Kurola J
    Anesth Analg; 2009 Mar; 108(3):790-2. PubMed ID: 19224785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy.
    Tsagalou EP; Nanas JN
    Resuscitation; 2006 Jan; 68(1):147-9. PubMed ID: 16325323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.
    Rossinen J; Harjola VP; Siirila-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS
    Acute Card Care; 2008; 10(4):209-13. PubMed ID: 18720087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Levosimendan for myocardiopathy due to acute Chagas' disease.
    de March Ronsoni R; Feijó RV; Melo LH; Schwingel FL; Filho WJ; de Albernaz Muniz RZ; Weber S; Moro A
    Int J Cardiol; 2009 Aug; 136(2):233-5. PubMed ID: 18662834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series.
    Lehmann A; Lang J; Boldt J; Isgro F; Kiessling AH
    Med Sci Monit; 2004 Aug; 10(8):MT89-93. PubMed ID: 15278007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
    Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.